个人中心 - 老虎社区

ThomasSim

IP属地：未知

帖子 · 32帖子 · 32
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- ThomasSimThomasSim
  ·2021-12-23
  Ya sia, ok ah
  Philips receives FDA De Novo Clearance for IVC Filter Removal Laser Sheath - CavaClear - with Breakthrough Device Designation
  Philips IVC Filter Removal Laser Sheath – CavaClear – is intended to safely ablate tissue to remove
  Philips receives FDA De Novo Clearance for IVC Filter Removal Laser Sheath - CavaClear - with Breakthrough Device Designation
  1,053 评论
  点赞
  分享
  举报
- ThomasSimThomasSim
  ·2021-10-28
  Tiger has HongKong License. Legally compliance.
  @forcec：
  $老虎证券(TIGR)$以个人信息安全为由头获取内地客户规模情况，以非法金融活动吹风，最终的命运是下架和清退。几乎是这个套路。
  $老虎证券(TIGR)$以个人信息安全为由头获取内地客户规模情况，以非法金融活动吹风，最终的命运是下架和清退。几乎是这个套路。
  953 评论
  点赞
  分享
  举报
- ThomasSimThomasSim
  ·2021-10-28
  $Tiger Brokers(TIGR)$eehh.. i tot Tiger got HongKong License? In other words like not really impacted? Lol
  2,641 1
  5
  分享
  举报
- ThomasSimThomasSim
  ·2021-10-27
  $Fiverr International Ltd.(FVRR)$hais
  1,829 2
  2
  分享
  举报
- ThomasSimThomasSim
  ·2021-10-15
  $Tiger Brokers(TIGR)$around 50-60% shorts for float. Gamma squeeze target.
  1,360 1
  7
  分享
  举报
- ThomasSimThomasSim
  ·2021-10-15
  $Tiger Brokers(TIGR)$tigr shorts should be around 50-60% now.
  984 评论
  点赞
  分享
  举报
- ThomasSimThomasSim
  ·2021-08-15
  PROTERRA
  非常抱歉，此主贴已删除
  668 评论
  1
  分享
  举报
- ThomasSimThomasSim
  ·2021-07-16
  Great
  @Srikanth：
  This is moving crazy
  This is moving crazy
  595 评论
  点赞
  分享
  举报
- ThomasSimThomasSim
  ·2021-07-16
  Fk it
  @YongKhin：
  $Proterra Inc.(PTRA)$9 more percent
  $Proterra Inc.(PTRA)$9 more percent
  472 评论
  点赞
  分享
  举报
- ThomasSimThomasSim
  ·2021-07-15
  Nice nice
  非常抱歉，此主贴已删除
  461 1
  5
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3566283048885824","uuid":"3566283048885824","gmtCreate":1603190857112,"gmtModify":1623247198676,"name":"ThomasSim","pinyin":"thomassim","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/5ae8ed8301f80085926169333185d321","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":38,"tweetSize":32,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.22","exceedPercentage":"93.30%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.17%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":9,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":691282938,"gmtCreate":1640206448271,"gmtModify":1640206448397,"author":{"id":"3566283048885824","authorId":"3566283048885824","name":"ThomasSim","avatar":"https://static.tigerbbs.com/5ae8ed8301f80085926169333185d321","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566283048885824","authorIdStr":"3566283048885824"},"themes":[],"htmlText":"Ya sia, ok ah","listText":"Ya sia, ok ah","text":"Ya sia, ok ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691282938","repostId":"2193927561","repostType":4,"repost":{"id":"2193927561","kind":"news","pubTimestamp":1640184600,"share":"https://www.laohunote.com/m/news/2193927561?lang=&edition=full","pubTime":"2021-12-22 22:50","market":"us","language":"en","title":"Philips receives FDA De Novo Clearance for IVC Filter Removal Laser Sheath - CavaClear - with Breakthrough Device Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2193927561","media":"GlobeNewswire","summary":"Philips IVC Filter Removal Laser Sheath – CavaClear – is intended to safely ablate tissue to remove ","content":"<ul>\n <li><i>Philips IVC Filter Removal Laser Sheath – CavaClear – is intended to safely ablate tissue to remove embedded IVC filters</i></li>\n <li><i>CavaClear is a first-in-class FDA-cleared solution for advanced IVC filter removal</i></li>\n <li><i>It is estimated that in the United States more than <a href=\"https://laohu8.com/S/AONE.U\">one</a> million patients with IVC filters would benefit from filter removal to reduce the risk of long-term complications [1,2]</i></li>\n <li><i><a href=\"https://laohu8.com/S/TWOA.U\">Two</a> independent and prospective clinical studies demonstrated that laser-assisted retrieval was 96-99.4% effective with a major adverse event rate of 0.7-2% [3,4]</i></li>\n</ul>\n<p><b>Amsterdam, the Netherlands –</b> <u>Royal Philips</u> (NYSE: PHG, AEX: PHIA), a global leader in health technology today announced the FDA has granted De Novo Clearance for Philips IVC Filter Removal Laser Sheath – CavaClear – to remove an IVC filter when previous methods of removal have failed. CavaClear is the first and only FDA-cleared solution for advanced IVC filter removal. Earlier in 2021, the FDA granted the device <u>Breakthrough Device Designation</u>. Laser has been clinically proven to provide a success rate over 99%, with low complication rates [3].</p>\n<p>IVC filters are used to treat patients with venous thromboembolism, in which blood clots form in the deep veins of the leg and groin, and can travel through the circulatory system. They are placed in the inferior vena cava to capture blood clots from moving to the lungs. However, research has shown that IVC filters may have long-term complications [5]. The filters can fracture and travel through the bloodstream to other parts of the body. Other identified long-term risks associated with IVC filters include lower limb deep vein thrombosis and IVC occlusion. The FDA recommends that implanting physicians consider removing retrievable IVC filters as soon as they are no longer indicated [2].</p>\n<p>Failure rates for IVC filter removal can be high and prior to CavaClear, limited options for removal existed if the filter became difficult to remove. Advanced retrieval tools and techniques are required if the IVC filter becomes embedded in the vasculature. Physicians previously had very few tools to remove the filter when complications occurred and until now there were no FDA-approved devices for this type of advanced removal.</p>\n<p>“Today is a historic day. With the approval of CavaClear, physicians now have a device specifically geared remove chronically embedded IVC filters,” said Kush R. Desai MD, FSIR, Associate Professor of Radiology, Surgery, and Medicine, and Director of Deep Venous Interventions at Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. “Backed by evidence, this technology can be applied to retrieve IVC filters that are no longer indicated, reducing potential clinical risk for patients and satisfying the FDA’s guidance to retrieve filters when they are no longer indicated.”</p>\n<p><b>Clinical research supports laser-assisted removal</b></p>\n<p><a href=\"https://laohu8.com/S/TWOA\">Two</a> independent and prospective clinical studies demonstrated that laser-assisted retrieval was 96-99.4% effective with a major adverse event rate of 0.7-2% [3,4]. Philips CavaClear uses circumferential tissue ablation that can aid in capturing the filter within seconds of laser activation, which can help increase physician efficiency during removal, and may help lower costs by reducing the number of retrieval attempts needed to remove an embedded filter. In addition, the simple and safe design is easy for physicians to integrate into their workflow.</p>\n<p>“With the FDA’s clearance of our IVC Filter Removal Laser Sheath – CavaClear – more than one million patients and their physicians now have access to a safe, effective and efficient option for advanced IVC filter removal,” said Chris Landon, Senior Vice President and General Manager Image Guided Therapy Devices at Philips. “This clearance demonstrates the commitment of Philips to innovating procedures with physician collaboration to meet unmet needs that can have a critical impact on the lives of patients and their families.”</p>\n<p>[1] Philips internal market research data calculation.</p>\n<p>[2] <u>Health, C. for D. and R. Safety Communications - Removing Retrievable Inferior Vena Cava Filters: FDA Safety Communication. (2014)</u>.</p>\n<p>[3] Kuo, W. et al. Laser‐Assisted Removal of Embedded Vena Cava Filters: A First‐In‐Human Escalation Trial in 500 Patients Refractory to High‐Force Retrieval.&nbsp;Journal of the American Heart Association&nbsp;9:24, 1-9 (2020).</p>\n<p>[4] Desai, K. et al. Excimer Laser Sheath-Assisted Retrieval of “Closed-Cell” Design Inferior Vena Cava Filters. J Am Heart Assoc; 9: e017240 (2020).</p>\n<p>[5] Van Ha, T. G. Complications of inferior vena caval filters. <i>Semin. Interv. Radiol.</i> 23, 150–155 (2006).</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Philips receives FDA De Novo Clearance for IVC Filter Removal Laser Sheath - CavaClear - with Breakthrough Device Designation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPhilips receives FDA De Novo Clearance for IVC Filter Removal Laser Sheath - CavaClear - with Breakthrough Device Designation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 22:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/philips-receives-fda-novo-clearance-140000021.html><strong>GlobeNewswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Philips IVC Filter Removal Laser Sheath – CavaClear – is intended to safely ablate tissue to remove embedded IVC filters\nCavaClear is a first-in-class FDA-cleared solution for advanced IVC filter ...</p>\n\n<a href=\"https://finance.yahoo.com/news/philips-receives-fda-novo-clearance-140000021.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4082":"医疗保健设备","PHG":"飞利浦"},"source_url":"https://finance.yahoo.com/news/philips-receives-fda-novo-clearance-140000021.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2193927561","content_text":"Philips IVC Filter Removal Laser Sheath – CavaClear – is intended to safely ablate tissue to remove embedded IVC filters\nCavaClear is a first-in-class FDA-cleared solution for advanced IVC filter removal\nIt is estimated that in the United States more than one million patients with IVC filters would benefit from filter removal to reduce the risk of long-term complications [1,2]\nTwo independent and prospective clinical studies demonstrated that laser-assisted retrieval was 96-99.4% effective with a major adverse event rate of 0.7-2% [3,4]\n\nAmsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology today announced the FDA has granted De Novo Clearance for Philips IVC Filter Removal Laser Sheath – CavaClear – to remove an IVC filter when previous methods of removal have failed. CavaClear is the first and only FDA-cleared solution for advanced IVC filter removal. Earlier in 2021, the FDA granted the device Breakthrough Device Designation. Laser has been clinically proven to provide a success rate over 99%, with low complication rates [3].\nIVC filters are used to treat patients with venous thromboembolism, in which blood clots form in the deep veins of the leg and groin, and can travel through the circulatory system. They are placed in the inferior vena cava to capture blood clots from moving to the lungs. However, research has shown that IVC filters may have long-term complications [5]. The filters can fracture and travel through the bloodstream to other parts of the body. Other identified long-term risks associated with IVC filters include lower limb deep vein thrombosis and IVC occlusion. The FDA recommends that implanting physicians consider removing retrievable IVC filters as soon as they are no longer indicated [2].\nFailure rates for IVC filter removal can be high and prior to CavaClear, limited options for removal existed if the filter became difficult to remove. Advanced retrieval tools and techniques are required if the IVC filter becomes embedded in the vasculature. Physicians previously had very few tools to remove the filter when complications occurred and until now there were no FDA-approved devices for this type of advanced removal.\n“Today is a historic day. With the approval of CavaClear, physicians now have a device specifically geared remove chronically embedded IVC filters,” said Kush R. Desai MD, FSIR, Associate Professor of Radiology, Surgery, and Medicine, and Director of Deep Venous Interventions at Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. “Backed by evidence, this technology can be applied to retrieve IVC filters that are no longer indicated, reducing potential clinical risk for patients and satisfying the FDA’s guidance to retrieve filters when they are no longer indicated.”\nClinical research supports laser-assisted removal\nTwo independent and prospective clinical studies demonstrated that laser-assisted retrieval was 96-99.4% effective with a major adverse event rate of 0.7-2% [3,4]. Philips CavaClear uses circumferential tissue ablation that can aid in capturing the filter within seconds of laser activation, which can help increase physician efficiency during removal, and may help lower costs by reducing the number of retrieval attempts needed to remove an embedded filter. In addition, the simple and safe design is easy for physicians to integrate into their workflow.\n“With the FDA’s clearance of our IVC Filter Removal Laser Sheath – CavaClear – more than one million patients and their physicians now have access to a safe, effective and efficient option for advanced IVC filter removal,” said Chris Landon, Senior Vice President and General Manager Image Guided Therapy Devices at Philips. “This clearance demonstrates the commitment of Philips to innovating procedures with physician collaboration to meet unmet needs that can have a critical impact on the lives of patients and their families.”\n[1] Philips internal market research data calculation.\n[2] Health, C. for D. and R. Safety Communications - Removing Retrievable Inferior Vena Cava Filters: FDA Safety Communication. (2014).\n[3] Kuo, W. et al. Laser‐Assisted Removal of Embedded Vena Cava Filters: A First‐In‐Human Escalation Trial in 500 Patients Refractory to High‐Force Retrieval. Journal of the American Heart Association 9:24, 1-9 (2020).\n[4] Desai, K. et al. Excimer Laser Sheath-Assisted Retrieval of “Closed-Cell” Design Inferior Vena Cava Filters. J Am Heart Assoc; 9: e017240 (2020).\n[5] Van Ha, T. G. Complications of inferior vena caval filters. Semin. Interv. Radiol. 23, 150–155 (2006).","news_type":1},"isVote":1,"tweetType":1,"viewCount":1053,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":854942514,"gmtCreate":1635414882300,"gmtModify":1635414965590,"author":{"id":"3566283048885824","authorId":"3566283048885824","name":"ThomasSim","avatar":"https://static.tigerbbs.com/5ae8ed8301f80085926169333185d321","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566283048885824","authorIdStr":"3566283048885824"},"themes":[],"htmlText":"Tiger has HongKong License. Legally compliance.","listText":"Tiger has HongKong License. Legally compliance.","text":"Tiger has HongKong License. Legally compliance.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/854942514","repostId":"854954454","repostType":1,"repost":{"id":854954454,"gmtCreate":1635414280215,"gmtModify":1635414471718,"author":{"id":"3518983480179242","authorId":"3518983480179242","name":"forcec","avatar":"https://static.tigerbbs.com/752def79475c77ddbeaceabf192b8c5d","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3518983480179242","authorIdStr":"3518983480179242"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>以个人信息安全为由头获取内地客户规模情况，以非法金融活动吹风，最终的命运是下架和清退。几乎是这个套路。","listText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>以个人信息安全为由头获取内地客户规模情况，以非法金融活动吹风，最终的命运是下架和清退。几乎是这个套路。","text":"$老虎证券(TIGR)$以个人信息安全为由头获取内地客户规模情况，以非法金融活动吹风，最终的命运是下架和清退。几乎是这个套路。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/854954454","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":953,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":854029178,"gmtCreate":1635411502561,"gmtModify":1635411685942,"author":{"id":"3566283048885824","authorId":"3566283048885824","name":"ThomasSim","avatar":"https://static.tigerbbs.com/5ae8ed8301f80085926169333185d321","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566283048885824","authorIdStr":"3566283048885824"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>eehh.. i tot Tiger got HongKong License? In other words like not really impacted? Lol","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>eehh.. i tot Tiger got HongKong License? In other words like not really impacted? Lol","text":"$Tiger Brokers(TIGR)$eehh.. i tot Tiger got HongKong License? In other words like not really impacted? Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/854029178","isVote":1,"tweetType":1,"viewCount":2641,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":852736071,"gmtCreate":1635301474432,"gmtModify":1635301508927,"author":{"id":"3566283048885824","authorId":"3566283048885824","name":"ThomasSim","avatar":"https://static.tigerbbs.com/5ae8ed8301f80085926169333185d321","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566283048885824","authorIdStr":"3566283048885824"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FVRR\">$Fiverr International Ltd.(FVRR)$</a>hais","listText":"<a href=\"https://laohu8.com/S/FVRR\">$Fiverr International Ltd.(FVRR)$</a>hais","text":"$Fiverr International Ltd.(FVRR)$hais","images":[{"img":"https://static.tigerbbs.com/fbf74a8f4d8721100dbe1d28d827cf26","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/852736071","isVote":1,"tweetType":1,"viewCount":1829,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":824877060,"gmtCreate":1634305910155,"gmtModify":1634306364271,"author":{"id":"3566283048885824","authorId":"3566283048885824","name":"ThomasSim","avatar":"https://static.tigerbbs.com/5ae8ed8301f80085926169333185d321","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566283048885824","authorIdStr":"3566283048885824"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>around 50-60% shorts for float. Gamma squeeze target.","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>around 50-60% shorts for float. Gamma squeeze target.","text":"$Tiger Brokers(TIGR)$around 50-60% shorts for float. Gamma squeeze target.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/824877060","isVote":1,"tweetType":1,"viewCount":1360,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":824873198,"gmtCreate":1634305591012,"gmtModify":1634306083758,"author":{"id":"3566283048885824","authorId":"3566283048885824","name":"ThomasSim","avatar":"https://static.tigerbbs.com/5ae8ed8301f80085926169333185d321","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566283048885824","authorIdStr":"3566283048885824"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>tigr shorts should be around 50-60% now.","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>tigr shorts should be around 50-60% now.","text":"$Tiger Brokers(TIGR)$tigr shorts should be around 50-60% now.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/824873198","isVote":1,"tweetType":1,"viewCount":984,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":830390036,"gmtCreate":1629007465625,"gmtModify":1631890295587,"author":{"id":"3566283048885824","authorId":"3566283048885824","name":"ThomasSim","avatar":"https://static.tigerbbs.com/5ae8ed8301f80085926169333185d321","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566283048885824","authorIdStr":"3566283048885824"},"themes":[],"htmlText":"PROTERRA","listText":"PROTERRA","text":"PROTERRA","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/830390036","repostId":"1138531277","repostType":4,"isVote":1,"tweetType":1,"viewCount":668,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170222220,"gmtCreate":1626437828360,"gmtModify":1631890295599,"author":{"id":"3566283048885824","authorId":"3566283048885824","name":"ThomasSim","avatar":"https://static.tigerbbs.com/5ae8ed8301f80085926169333185d321","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566283048885824","authorIdStr":"3566283048885824"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/170222220","repostId":"170631779","repostType":1,"repost":{"id":170631779,"gmtCreate":1626425364991,"gmtModify":1631892324704,"author":{"id":"4087821855695230","authorId":"4087821855695230","name":"Srikanth","avatar":"https://static.tigerbbs.com/4b3ea20f2e2f984cdc111f2c5e42e603","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087821855695230","authorIdStr":"4087821855695230"},"themes":[],"htmlText":"This is moving crazy","listText":"This is moving crazy","text":"This is moving crazy","images":[{"img":"https://static.tigerbbs.com/685e8ab98579162550ec0b9203f5e640","width":"1125","height":"3291"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/170631779","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":595,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170685583,"gmtCreate":1626426956542,"gmtModify":1631890295614,"author":{"id":"3566283048885824","authorId":"3566283048885824","name":"ThomasSim","avatar":"https://static.tigerbbs.com/5ae8ed8301f80085926169333185d321","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566283048885824","authorIdStr":"3566283048885824"},"themes":[],"htmlText":"Fk it","listText":"Fk it","text":"Fk it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/170685583","repostId":"147650583","repostType":1,"repost":{"id":147650583,"gmtCreate":1626357043542,"gmtModify":1631886774526,"author":{"id":"3571894533961978","authorId":"3571894533961978","name":"YongKhin","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571894533961978","authorIdStr":"3571894533961978"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PTRA\">$Proterra Inc.(PTRA)$</a>9 more percent&nbsp;","listText":"<a href=\"https://laohu8.com/S/PTRA\">$Proterra Inc.(PTRA)$</a>9 more percent&nbsp;","text":"$Proterra Inc.(PTRA)$9 more percent","images":[{"img":"https://static.tigerbbs.com/2bc9c1120430efc9e93f10c18e44622e","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/147650583","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":472,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":147613812,"gmtCreate":1626356009636,"gmtModify":1631890295630,"author":{"id":"3566283048885824","authorId":"3566283048885824","name":"ThomasSim","avatar":"https://static.tigerbbs.com/5ae8ed8301f80085926169333185d321","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566283048885824","authorIdStr":"3566283048885824"},"themes":[],"htmlText":"Nice nice","listText":"Nice nice","text":"Nice nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/147613812","repostId":"2151526974","repostType":4,"isVote":1,"tweetType":1,"viewCount":461,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}